Inactief instrument

Andere talen Amoy Diagnostics Co Ltd Shenzhen S.E.

Aandelen

slotkoers Shenzhen S.E. Andere beurzen
- ^CNY	-

13/06	Amoy Diagnostics krijgt certificaat voor registratie PCR analyzer	MT
22/04	Amoy Diagnostics Co. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Amoy Diagnostics Gets Certificate to Register PCR Analyzer	13/06
Amoy Diagnostics Co., Ltd. Announces Cash Dividend on A Shares for the Year 2023, Payable on 30 May 2024	24/05
Amoy Diagnostics Co., Ltd. Approves Final Cash Dividend for 2023	14/05
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	15/04
Amoy Diagnostics Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on February 26, 2024.	01/04
Amoy Diagnostics Co., Ltd.(SZSE:300685) dropped from Shenzhen Stock Exchange Component A Share Index	11/12
Amoy Diagnostics Co., Ltd.(SZSE:300685) dropped from Shenzhen Stock Exchange Component Index	11/12
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	31-07-23
Amoy Diagnostics to Collaborate with AstraZeneca Unit for Ovarian Cancer Companion Diagnostic in China	26-07-23
Amoy Diagnostics Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date of 23 May 2023	16-05-23
Amoy Diagnostics Co., Ltd. Approves Final Dividend for 2022	12-05-23
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	21-04-23
Amoy Diagnostics Co., Ltd. Proposes Final Cash Dividend for the Year 2022	17-04-23
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14-04-23
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC	27-03-23
Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd. and Precision Medicine Asia Co., Ltd. Announces the Japanese Ministry of Health, Labour and Welfare Approval in Japan as a Companion Diagnostic for Ret Fusion-Positive NSCLC	27-03-23
Tranche Update on Amoy Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 14, 2022.	14-02-23
Amoy Diagnostics Co., Ltd.'s Equity Buyback announced on February 13, 2023 has expired with 3,943,726 shares, representing 1% for CNY 112.01 million.	13-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Amoy Diagnostics Co Ltd Shenzhen S.E.

Aandelen

Andere talen

Filters